High
FREM2
SPRY1
TCGA
glioblastoma
malignancy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
27 Jul 2019
27 Jul 2019
Historique:
received:
10
07
2019
revised:
24
07
2019
accepted:
25
07
2019
entrez:
31
7
2019
pubmed:
31
7
2019
medline:
31
7
2019
Statut:
epublish
Résumé
World Health Organization grade IV diffuse gliomas, known as glioblastomas, are the most common malignant brain tumors, and they show poor prognosis. Multimodal treatment of surgery followed by radiation and chemotherapy is not sufficient to increase patient survival, which is 12 to 18 months after diagnosis. Despite extensive research, patient life expectancy has not significantly improved over the last decade. Previously, we identified
Identifiants
pubmed: 31357584
pii: cancers11081060
doi: 10.3390/cancers11081060
pmc: PMC6721429
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Javna Agencija za Raziskovalno Dejavnost RS
ID : P1-0390
Organisme : Javna Agencija za Raziskovalno Dejavnost RS
ID : Z3-1869
Organisme : European Regional Development Fund
ID : Ref. No. 146, TRANS-GLIOMA
Références
Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
pubmed: 12184808
Am J Clin Oncol. 2004 Feb;27(1):33-8
pubmed: 14758131
Cancer Res. 2004 Aug 1;64(15):5245-50
pubmed: 15289330
Cancer Lett. 2006 Oct 28;242(2):141-50
pubmed: 16469433
Acta Neuropathol. 2007 Aug;114(2):97-109
pubmed: 17618441
Trends Mol Med. 2008 May;14(5):228-35
pubmed: 18403264
N Engl J Med. 2008 Jul 31;359(5):492-507
pubmed: 18669428
BMC Mol Biol. 2009 Mar 03;10:17
pubmed: 19257903
Expert Opin Investig Drugs. 2009 Aug;18(8):1061-83
pubmed: 19555299
Clin Cancer Res. 2009 Jul 15;15(14):4622-9
pubmed: 19584161
Int J Biochem Cell Biol. 2011 Apr;43(4):487-95
pubmed: 21182980
Cancer Res. 2011 Jun 15;71(12):4055-60
pubmed: 21628493
J Neurooncol. 2012 Apr;107(2):359-64
pubmed: 22045118
Cancer Cell. 2011 Dec 13;20(6):810-7
pubmed: 22137795
Am J Pathol. 2012 May;180(5):1816-23
pubmed: 22538188
Int J Legal Med. 2012 Nov;126(6):943-52
pubmed: 23010907
Science. 2012 Nov 23;338(6110):1080-4
pubmed: 23087000
PLoS One. 2013 Oct 14;8(10):e77098
pubmed: 24155920
JAMA. 2013 Nov 6;310(17):1842-50
pubmed: 24193082
Tumour Biol. 2014 May;35(5):5037-48
pubmed: 24510305
N Engl J Med. 2014 Feb 20;370(8):709-22
pubmed: 24552318
Nat Rev Neurosci. 2014 Jul;15(7):455-65
pubmed: 24946761
Eur J Cancer. 2014 Sep;50(13):2309-18
pubmed: 24972545
Cancer Discov. 2014 Nov;4(11):1299-309
pubmed: 25139148
Pathol Oncol Res. 2014 Oct;20(4):777-87
pubmed: 25156108
Neurosurg Focus. 2014 Dec;37(6):E11
pubmed: 25434380
Am J Cancer Res. 2014 Nov 19;4(6):683-97
pubmed: 25520860
Proc Natl Acad Sci U S A. 2015 Jan 20;112(3):851-6
pubmed: 25561528
Sci Rep. 2015 Jan 21;5:7915
pubmed: 25604826
Sci Rep. 2015 Jan 27;5:7979
pubmed: 25623281
Contemp Oncol (Pozn). 2015;19(1A):A68-77
pubmed: 25691825
Ann Transl Med. 2015 Jan;3(1):7
pubmed: 25705639
Neoplasia. 2015 Mar;17(3):239-55
pubmed: 25810009
Oncotarget. 2015 Mar 30;6(9):7318-24
pubmed: 25821160
J Neurooncol. 2015 May;123(1):35-42
pubmed: 25862007
Acta Neuropathol. 2015 Jun;129(6):829-48
pubmed: 25943888
Brain Pathol. 2016 Jul;26(4):517-22
pubmed: 26443480
Cell. 2016 Jan 28;164(3):550-63
pubmed: 26824661
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Nat Genet. 2016 Jul;48(7):768-76
pubmed: 27270107
Oncotarget. 2016 Sep 13;7(37):59098-59114
pubmed: 27385209
Acta Neuropathol Commun. 2016 Aug 08;4(1):79
pubmed: 27503138
Oncotarget. 2017 Jul 4;8(27):44141-44158
pubmed: 28498803
J Neurooncol. 2017 Jul;133(3):455-467
pubmed: 28527008
ESMO Open. 2017 Feb 22;1(6):e000144
pubmed: 28912963
J Neurooncol. 2018 Jan;136(1):155-162
pubmed: 29079955
Eur Rev Med Pharmacol Sci. 2017 Nov;21(22):5072-5080
pubmed: 29228449
Neuro Oncol. 2018 Sep 3;20(10):1300-1309
pubmed: 29452419
Oncotarget. 2017 Dec 15;9(8):7844-7858
pubmed: 29487696
Pathol Res Pract. 2018 May;214(5):679-685
pubmed: 29615337
Contemp Oncol (Pozn). 2018 Mar;22(1A):81-85
pubmed: 29628799
Pharmacol Rev. 2018 Jul;70(3):412-445
pubmed: 29669750
Int J Mol Sci. 2018 May 04;19(5):null
pubmed: 29734672
J Clin Neurosci. 2018 Aug;54:7-13
pubmed: 29801989
Oxid Med Cell Longev. 2018 Mar 21;2018:8753063
pubmed: 29849920
Cancer Lett. 2018 Oct 1;433:176-185
pubmed: 29991446